Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Bostwick

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
BJU International|April 25, 2009
Precursor of prostate-specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 casesDavid Hull, Jun Ma, Harpreet Singh, et al.
International Journal of Surgical Pathology|May 3, 2005
Atypical adenomatous hyperplasia (adenosis) of the prostate: DNA ploidy analysis and immunophenotypeAntonio Lopez-Beltran, Junqi Qian, Rodolfo Montironi, et al.
Histopathology|January 4, 2012
Staging of prostate cancerLiang Cheng, Rodolfo Montironi, David G Bostwick, et al.
Digestive Diseases and Sciences|October 2, 2002
Graft-versus-host-like colitis and malignant thymomaPhilip W Lowry, John D Myers, Alex Geller, et al.
European Urology|August 26, 2006
Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy")Rodolfo Montironi, Vincenzo Scattoni, Roberta Mazzucchelli, et al.
American Journal of Clinical Pathology|September 25, 2003
Distinguishing atrophy and high-grade prostatic intraepithelial neoplasia from prostatic adenocarcinoma with and without previous adjuvant hormone therapy with the aid of cytokeratin 5/6Neil A Abrahams, David G Bostwick, Adrian H Ormsby, et al.
Human Pathology|July 16, 2005
Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimensRodolfo Montironi, Roberta Mazzucchelli, Alfredo Santinelli, et al.
BJU International|December 22, 2004
Hyperbaric oxygen does not accelerate latent in vivo prostate cancer: implications for the treatment of radiation-induced haemorrhagic cystitisKian Tai Chong, Neil B Hampson, David G Bostwick, et al.
Reviews in Urology|March 25, 2014
Utilization trends and positive biopsy rates for prostate biopsies in the United States: 2005 to 2011Deepak A Kapoor, David G Bostwick, Savvas E Mendrinos, et al.
Archives of Pathology & Laboratory Medicine|November 29, 2013
Comparison of Classic and International Society of Urological Pathology 2005 Modified Gleason grading using needle biopsies from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trialM Scott Lucia, David G Bostwick, Matthew C Somerville, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
BJU International|April 25, 2009
Precursor of prostate-specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 casesDavid Hull, Jun Ma, Harpreet Singh, et al.
International Journal of Surgical Pathology|May 3, 2005
Atypical adenomatous hyperplasia (adenosis) of the prostate: DNA ploidy analysis and immunophenotypeAntonio Lopez-Beltran, Junqi Qian, Rodolfo Montironi, et al.
Histopathology|January 4, 2012
Staging of prostate cancerLiang Cheng, Rodolfo Montironi, David G Bostwick, et al.
Digestive Diseases and Sciences|October 2, 2002
Graft-versus-host-like colitis and malignant thymomaPhilip W Lowry, John D Myers, Alex Geller, et al.
European Urology|August 26, 2006
Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy")Rodolfo Montironi, Vincenzo Scattoni, Roberta Mazzucchelli, et al.
American Journal of Clinical Pathology|September 25, 2003
Distinguishing atrophy and high-grade prostatic intraepithelial neoplasia from prostatic adenocarcinoma with and without previous adjuvant hormone therapy with the aid of cytokeratin 5/6Neil A Abrahams, David G Bostwick, Adrian H Ormsby, et al.
Human Pathology|July 16, 2005
Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimensRodolfo Montironi, Roberta Mazzucchelli, Alfredo Santinelli, et al.
BJU International|December 22, 2004
Hyperbaric oxygen does not accelerate latent in vivo prostate cancer: implications for the treatment of radiation-induced haemorrhagic cystitisKian Tai Chong, Neil B Hampson, David G Bostwick, et al.
Reviews in Urology|March 25, 2014
Utilization trends and positive biopsy rates for prostate biopsies in the United States: 2005 to 2011Deepak A Kapoor, David G Bostwick, Savvas E Mendrinos, et al.
Archives of Pathology & Laboratory Medicine|November 29, 2013
Comparison of Classic and International Society of Urological Pathology 2005 Modified Gleason grading using needle biopsies from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trialM Scott Lucia, David G Bostwick, Matthew C Somerville, et al.
Pageof 12